Immatics (IMTX) had the highest return in 2018 by a US stock with a market cap of $300M to $2B or a market cap of $200B+, returning 195,900%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Immatics (IMTX) | 2018 | 195,900% |
Tandem Diabetes Care (TNDM) | 2018 | 1,515.74% |
Turtle Beach (TBCH) | 2018 | 678.93% |
Semler Scientific (SMLR) | 2018 | 358.67% |
Xpel (XPEL) | 2018 | 326.68% |
Quantum Computing (QUBT) | 2018 | 275% |
CareDx (CDNA) | 2018 | 240.19% |
Arrowhead Pharmaceuticals (ARWR) | 2018 | 236.59% |
Harrow Health (HROW) | 2018 | 234.71% |
Vericel Corp Ord (VCEL) | 2018 | 213.51% |
Tilray (TLRY) | 2018 | 206.03% |
American Superconductor (AMSC) | 2018 | 201.35% |
Pacific Biosciences of California (PACB) | 2018 | 177.15% |
BlueLinx (BXC) | 2018 | 152.92% |
CorMedix (CRMD) | 2018 | 148.08% |
KULR Technology (KULR) | 2018 | 136.36% |
Amerant Bancorp (AMTB) | 2018 | 116.83% |
Acm Research (ACMR) | 2018 | 107.24% |
Kalvista Pharmaceuticals (KALV) | 2018 | 105.73% |
STAAR Surgical (STAA) | 2018 | 103.9% |
Vaalco Energy (EGY) | 2018 | 102.74% |
BioLife Solutions (BLFS) | 2018 | 100.5% |
Magnite (MGNI) | 2018 | 99.47% |
Addus HomeCare (ADUS) | 2018 | 94.5% |
QuinStreet (QNST) | 2018 | 93.21% |
